This is supported by the downregulation of the E3 ubiquitin ligases MAFbx and MuRF1, hallmarks of skeletal muscle atrophy, and activation of key nodes in protein synthesis, S6K1 and eIF4E. The gene discussed is FBXO32; the disease is muscle atrophy.